Background: Premature ejaculation (PE) is the most common form of male sexual dysfunction. Treatment modalities include behavioral therapy and medical therapy. No therapy is approved by the FDA for treatment of PE. Pregabalin exerts a negative effect on sexuality by reducing central nervous excitatory transmission via sodium and calcium channel inhibition and potassium (k) channel activation and by unbalancing dopamine serotonine ratio.
INTRODUCTION
remature ejaculation (PE) is the most common form of male sexual dysfunction. Globally, between 20% and 40% of men, at some point in their lives, have reported complaint of PE Premature ejaculation (PE) may be classified as lifelong or acquired. Lifelong PE is characterized by early ejaculation in the majority of intercourse attempts with nearly every partner from the first sexual encounter onwards, whereas acquired PE develops at some point in a man's life after he has previously experienced normal ejaculation and may be linked to urological or psychological problems (2) It is so difficult to get an accurate definition and diagnosis of premature ejaculation. Recently; The International Society of Sexual Medicine (ISSM) produced its guidelines of the diagnosis and management of PE. It postulated an evidence-based definition of PE and defined PE as -A male sexual dysfunction characterized by ejaculation which is always or nearly always occurs prior to or within 1 minute of vaginal penetration; and an inability to delay ejaculation on all or nearly all vaginal penetrations, and negative personal consequences, such as distress, bother, frustration, and/or the avoidance of sexual encounters‖
Premature ejaculation has been associated with erosion in sexual self-confidence and low sexual satisfaction in men and their female partners Premature ejaculation up till now has no definitive etiopathology, investigation or effective treatment. The etiology of premature ejaculation has included a diverse range of biogenic and psychological theories. Most of these proposed etiologies are speculative and not evidence based (6) Treatment modalities include behavioral therapy and medical therapy. No therapy is approved by the FDA for treatment of PE, A range of drugs is currently used by clinicians for the management of PE; antidepressants including Selective Serotonin Re-uptake Inhibitors (SSRIs), local anesthetic agents and phosphodiesterase type 5 inhibitors Pregabalin exerts a negative effect on sexuality by reducing central nervous excitatory transmission via sodium and calcium channel inhibition and potassium (k) channel activation and by unbalancing dopamine serotonine ratio. Mofadinil used in treatment of narcolepsy, Act through activation of central dopaminergic and serotonin pathways. It showed good results in treatment of PE (8) The aim of this work was to assess the efficacy and safety of oral on demand pregabalin in treatment of premature ejaculation (PE).
SUBJECTS AND METHODS This study was conducted on 96 married male patients with primary premature ejaculation (lifelong). All patients were recruited from the andrology outpatient clinic at Al-Azhar University Hospitals (Cairo). Being married for at least 4 months, and in a stable relationship with regular sexual intercourse at least twice per week with a cooperative female partner.
3.
Normal erectile function. Exclusion criteria: 1.
Erectile dysfunction or other sexual dysfunction e.g. reduced sexual desire.
2.
Major psychiatric or psychological illness.
3.
Chronic medical disorders that may limit the usage of pregabalin.
4.
Men receiving medications that could affect ejaculatory function or interact with pregabalin.
5.
Sexual dysfunction in the female partner. 6.
Secondary premature ejaculation. 7.
Age less than 18 or more than 50. The patients were randomly assigned to three groups: Group A: This group included 36 patients. They will receive 150 mg pregabalin 1 -2 hours prior to sexual intercourse.
Group B:
This group included 30 patients. They will receive 75 mg pregabalin 1 -2 hours prior to sexual intercourse.
Group C:
This group included 30 patients, all of them received identical placebo capsules. All patient will be subjected to the following: 1.
Written concept; after explaining the nature of the study 2.
Full history: including age, baseline estimated ILET, erectile dysfunction, medical diseases and medications. 3.
Local and general physical examination.
4.
Couples were encouraged to engage in coitus twice a week and record estimated intravaginal ejaculation latency time (perceived IELT OR PIELT) every time for 2 weeks and report any side effects suspected to be drug related. Most guidelines state that stopwatch measured ILET should be the accepted method for ILET evaluation in clinical researches. However this method always associated with more performance anxiety which itself worsen the ILET. Also multiple researches proved that both stopwatch measured ILET and PILET are highly correlated 
STATISTICAL ANALYSIS
The data were coded, entered and processed on computer using SPSS (version 18). The results were represented in tabular and diagrammatic forms then interpreted. Mean, standard deviation, range, frequency, and percentage were use as descriptive statistics. The following test was done: Student's t-test was used to assess the statistical significance of the difference between two population means in a study involving independent samples. Student's paired t-test was used to assess the statistical significance of the difference between two population means in a study involving paired samples. ANOVA
Value was considered significant as the following: P > 0.05: Nonsignificant. P ≤ 0.05: Significant 4-Results: Eleven cases of all patients received pregabalin (in both group A & B) showed various side effects (16.6 %). They distribution were as follow; Eight out of thirty sex cases -group A (22.2 %).Three out of thirty cases -group B (10 %). Pregabalin was generally found to be well tolerated, with mild or no adverse effects. The experienced side effects are showed in Table 2 any medical treatments are currently administered off-label, and patients must therefore be counseled as to the risks and benefits of therapy. Treatments must additionally be individualized according to the type of PE complaint, as well as patient and partner preferences. In this study we assessed the efficacy and safety of on demand oral pregabalin in treatment of PE. The mean baseline PIELT values were similar across the treatment groups, with subjects having on average, a mean PIELT from their baseline attempts ranging between 0.25 minutes and 1 minutes. Our patients are men in sexual active age (22-44) years, all of them are in stable marriage, the mean PIELT should be less than one minute. Age distribution and mean PIELT are similar in all groups. Although most of the clinical trials use the stopwatch IELT as an evaluation tool, we choose the PIELT as an evaluation parameter in this study. This is due to several factors;  Most of the andrologist accept the PIELT as an evaluation method for PE in their practice.  Stopwatch IELT always accompanied with performance anxiety that may affect patient IELT. It is unpractical and difficult to use.  Recent multiple researches proved that both methods are markedly similar  The fraction of error in evaluating base IELT will be the same in the post treatment IELT, as the measuring method is identical.
Group A showed significant increase in the PIELTS from a mean of 0.69 + 0.24 min pretreatment to 1.22 + 0.51 min two weeks after treatment (P < 0.000). Group B Showed significant increase in PIELTS pre and post treatment (0.77 + 0.18, 0.87 + 0.35) respectively, however inspite of being significant, improvement is still subtle. Hitiris et al., (10) described a case of delayed ejaculation developed in a patient treated with daily pregabalin monotherapy in higher doses and for more prolonged time. The increase in IELTS during use of pregabalin 150 mg is not so long. Most of the patients received 75 mg pregabalin showed no improvement. These results and Hitiris report may indicate that, efficacy of pregabalin in treatment of PE may be augmented with larger doses and more prolonged duration. Wong and Malde, (9) systematically reviewed the efficacy of on demand tramadol as a treatment option for PE. On demand oral tramadol increased IELTS between 4 and 13 folds in multiple different series. As tramadol is a weak µ-opioid receptor agonist, concerns have been raised regarding the potential for drug dependence with the long-term ingestion of it, and this is the main reason limiting its more widespread use. On demand dapoxetine therapy one hour prior to sexual act, showed a reasonable efficacy with a 3 -4-fold increase of baseline IELT. Recently dapoxetine is proved to be characterized by high discontinuation rates of up to 90%, mostly because of high side effects, cost issues, efficacy below expectations, and the need for scheduling sexual intercourse (11) It is clear that both on demand tramadol and dapoxetine have more powerful efficacy than pregabalin. Pregabalin 150 mg increases ejaculatory time 2-3 folds in most of the cases. However, tramadol and dapoxetine usage is still hampered by multiple issues. As regard adverse events, it was minimal, not serious, tolerable, not sexually related and not lead to drug discontinuation. Bonnet and Scherbaum, (12) didn't find convincing evidence that pregabalin has an addictive power. Taking into consideration the small number of cases and short duration, we couldn't rely on this study to evaluate drug safety.
CONCLUSION AND RECOMMENDATION This is the first report of an oral pregabalin used for the treatment of PE in men. On demand oral pregabalin 150 mg 1 -2 hours prior to sexual relation, looks to be effective pharmacotherapy of PE. The effect of pregabalin is minimal and may be augmented with higher daily doses. Longerterm safety studies, and those comparing pregabalin with on demand tramadol and dapoxetine are essential to determine the place of pregabalin in the treatment of this distressing condition.
